Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 8 Leukemia, Myeloid, Acute 6 Neoplasm Metastasis 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Monocytic, Acute 4 Leukemia, Megakaryoblastic, Acute 4 Leukemia, Erythroblastic, Acute 4 Lung Neoplasms 3 Endometrial Neoplasms 3 Congenital Abnormalities 3 Colonic Neoplasms 3 Breast Neoplasms 3 Sarcoma 2 Oropharyngeal Neoplasms 2 Neuroblastoma 2 Melanoma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Eosinophilic, Acute 2 Leukemia, Basophilic, Acute 2 Leukemia 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Anus Neoplasms 2 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1

Interventions

Specimen Handling 2 Magnetic Resonance Spectroscopy 2 vinflunine 1 pembrolizumab 1 enfortumab vedotin 1 cabozantinib 1 avelumab 1 Watchful Waiting 1 Vitamin B 12 1 Platinum 1 Pemetrexed 1 Paclitaxel 1 Observation 1 Morphine 1 Immunoglobulin G 1 Gemcitabine 1 Folic Acid 1 Docetaxel 1 Disulfides 1 Dexamethasone 1 Cystoscopy 1 Cisplatin 1 Calcium Dobesilate 1 Bupivacaine 1 Bevacizumab 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Ureteral Neoplasms × Observation × Clear all

NCT03244384 2026-05-13

AMBASSADOR

National Cancer Institute (NCI)

Phase 3 Active not recruiting

Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡